Literature DB >> 8564628

Prevalence of latex-specific IgE antibodies in hospital personnel.

R G Kaczmarek1, B G Silverman, T P Gross, R G Hamilton, E Kessler, J T Arrowsmith-Lowe, R M Moore.   

Abstract

BACKGROUND: Rubber latex hypersensitivity is an important concern for health care workers.
PURPOSE: The Center for Devices and Radiological Health, in collaboration with the Consumer Product Safety Commission, conducted a multicenter study of the prevalence of latex-specific IgE antibodies among United States hospital personnel.
MATERIALS AND METHODS: Nine hospitals participated in the cross-sectional study. A total of 504 hospital personnel completed questionnaires that provided an array of demographic, occupational, and clinical information, including a history, if any, of allergies and the use of latex and nonlatex gloves. More than three-quarters (76.5%) of the participants were tested for total IgE and latex specific IgE.
RESULTS: A total of 21 (5.5%, 95% CI = 3%-7%) of the tested participants were positive for the presence of latex specific IgE antibodies, defined as a latex IgE level of > or = 0.6 ng/mL. Latex specific IgE antibodies were more prevalent in participants who reported tachycardia, palpitations, flushing, or wheezing associated with latex gloves (Odds Ratio = 10.2, 95% CI = 3.7-28.6).
CONCLUSION: The study's results suggest that the prevalence of latex-specific IgE antibodies among hospital personnel is appreciable and these personnel and their health care providers should be aware of this entity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564628     DOI: 10.1016/S1081-1206(10)63406-0

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  2 in total

1.  Hand hygiene practices among community Health Officers in Rivers State, Nigeria.

Authors:  O B Braimoh; S E Udeabor
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

2.  Latex allergy in clinical practice.

Authors:  R Pradeep Kumar
Journal:  Indian J Dermatol       Date:  2012-01       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.